Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies
出版年份 2011 全文链接
标题
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies
作者
关键词
-
出版物
BLOOD
Volume 117, Issue 21, Pages 5573-5581
出版商
American Society of Hematology
发表日期
2011-03-27
DOI
10.1182/blood-2011-01-270140
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications
- (2010) G. Bianchi et al. BLOOD
- Smoldering (Asymptomatic) Multiple Myeloma: Revisiting the Clinical Dilemma and Looking Into the Future
- (2010) Adam J. Waxman et al. Clinical Lymphoma Myeloma & Leukemia
- Initial versus deferred melphalan-prednisone therapy for asymptomatic multiple myeloma stage I - A randomized study
- (2010) Martin Hjorth et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis
- (2010) Arun Balakumaran et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Multiple Myeloma Precursor Disease
- (2010) Ola Landgren et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma
- (2010) Jens Hillengass et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study
- (2010) Angela Dispenzieri et al. LANCET
- Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
- (2010) R A Kyle et al. LEUKEMIA
- Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma
- (2010) Sham Mailankody et al. LEUKEMIA & LYMPHOMA
- Advances in the Diagnosis, Classification, Risk Stratification, and Management of Monoclonal Gammopathy of Undetermined Significance: Implications for Recategorizing Disease Entities in the Presence of Evolving Scientific Evidence
- (2010) S. Vincent Rajkumar et al. MAYO CLINIC PROCEEDINGS
- Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study
- (2009) O. Landgren et al. BLOOD
- A monoclonal gammopathy precedes multiple myeloma in most patients
- (2009) B. M. Weiss et al. BLOOD
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
- (2009) O. Landgren et al. BLOOD
- Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance
- (2009) C. M. Vachon et al. BLOOD
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging Identifies a Subgroup of Patients with Asymptomatic Monoclonal Plasma Cell Disease and Pathologic Microcirculation
- (2009) J. Hillengass et al. CLINICAL CANCER RESEARCH
- The Potential Role of Curcumin in Patients with Monoclonal Gammopathy of Undefined Significance--Its Effect on Paraproteinemia and the Urinary N-Telopeptide of Type I Collagen Bone Turnover Marker
- (2009) T. Golombick et al. CLINICAL CANCER RESEARCH
- Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context
- (2009) L. Chiecchio et al. HAEMATOLOGICA
- Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single case
- (2009) L. Chiecchio et al. HAEMATOLOGICA
- Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies
- (2009) S. Y. Kristinsson et al. HAEMATOLOGICA
- International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
- (2009) R Fonseca et al. LEUKEMIA
- International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
- (2009) M Dimopoulos et al. LEUKEMIA
- Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component
- (2009) John A. Lust et al. MAYO CLINIC PROCEEDINGS
- Seven-year median time to progression with thalidomide for smoldering myeloma: partial response identifies subset requiring earlier salvage therapy for symptomatic disease
- (2008) B. Barlogie et al. BLOOD
- A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma
- (2008) Pellegrino Musto et al. CANCER
- AID-Dependent Activation of a MYC Transgene Induces Multiple Myeloma in a Conditional Mouse Model of Post-Germinal Center Malignancies
- (2008) Marta Chesi et al. CANCER CELL
- Clinical and biological significance of RAS mutations in multiple myeloma
- (2008) W J Chng et al. LEUKEMIA
- MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
- (2008) F. Pichiorri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma
- (2007) A. Dispenzieri et al. BLOOD
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now